Archean Chemical Industries Merger & Restructuring Worth ₹170 Cr

Archean Chemical Industries Earnings Call Transcript: Key Takeaways

Q2 FY27: standalone income up 32% YoY to ₹305.4 Cr on bromine pricing; consolidated PAT only up 8%. H1 consolidated EBITDA down 5.2%; SOP guidance cut to 3.5–4k t, with fuel and PVC risks.

Archean Chemical Industries Investor Presentation: Key Takeaways

Q2FY27 consolidated income Rs301.6 Cr (+25.9% YoY), PAT Rs31.3 Cr (+7.9%). Bromine revenue +76%, bromine derivatives +81%. Strategy centres on SiC semiconductor fab and zinc-bromide batteries.

Archean Chemical Industries Employee Stock Options

Archean Chemical allotted 6,143 equity shares to one grantee under its ESOP 2022 on 29-Oct-2026. Paid-up capital rose to 12,34,64,537 shares.

Archean Chemical Industries Q2 FY27 Results: Net Profit ₹31.3 Cr, Up 7.9% YoY

Archean Chemical Industries Ltd reported revenue from operations of ₹297.4 Cr (+27.5% YoY) and net profit of ₹31.3 Cr (+7.9% YoY) for Q2 FY27.

Key figure

Net profit ₹31.3 Cr · +7.9% YoY

Archean Chemical Industries Credit Rating

Archean Chemical Industries Limited informed that CRISIL downgraded its ratings for ₹1,531 Crore in long-term bank facilities from CRISIL A/Negative to CRISIL A-/Stable.

Archean Chemical Industries Board Meeting Date

Archean Chemical Industries Limited scheduled a board meeting on October 29, 2026, to consider and approve the financial results for the quarter ended September 30, 2026.

Zydus Lifesciences Merger & Restructuring Worth ₹9.38 Cr

Zydus Lifesciences completed its ₹9.38 Crore 50% subscription in JV Zydus Sunshine Lifesciences. The transaction with Sunshine Healthcare Lanka was fully executed on November 11, 2026.

Value

₹9.38 Cr

Zydus Lifesciences Merger & Restructuring

Zydus completed its subscription for 50% of Zydus Sunshine, making it a 50:50 joint venture with Sunshine Healthcare Lanka. Completed November 11, 2026.

Spacenet Enterprises India Merger & Restructuring Worth ₹2.6 Cr

Spacenet sold 40,00,005 String Metaverse shares on 11 November 2026 at ₹6.49 each. Gross consideration of about ₹2.60 Crore is disclosed as material.

Value

₹2.60 Cr

Abans Financial Services Merger & Restructuring Worth ₹1.2 Cr

Abans Financial Services approved incorporating a Hong Kong subsidiary for bullion and securities trading. The cash consideration is Rs 1.20 Crore.

Value

₹1.20 Cr

Adani Enterprises Merger & Restructuring Worth ₹0.94 Cr

Adani Enterprises reported incorporation of Adani Rovuma Chemicals Limited in UAE on November 10, 2026, via Adani Global Limited. Cash consideration of Rs. 0.94 Crore was stated.

Value

₹0.94 Cr

Adani Enterprises Merger & Restructuring

Adani Enterprises' subsidiary Adani Global incorporated Adani Rovuma Chemicals Limited in UAE on November 10, 2026. It is a step-down subsidiary with USD 100,000 paid-up capital.